Delivery Order SPE2DB24D2205-SPE2DB24FDSHA
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The $36,608.23 contract has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceuticals. The $12,601.23 contract has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,458.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENBREL 50 MG/ML SURECLICK medication. The delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The $16,801.64 contract has an April 2024 completion date and does not include a set-aside designation. AmerisourceBergen Drug Corp, the prime contractor, provides a wide range of pharmaceutical and medical supplies to DLA Troop Support Medical and other...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The contract has a ceiling value of $24,929.65 and an ultimate completion date of March 21, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing $999,999,999.00 indefinite delivery contract with DLA, which serves as the primary vehicle...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product ENBREL 50 MG/ML SURECLICKML. The contract has a ceiling value of $11,966.22 and a period of performance through April 12, 2024. This delivery order is placed under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, which has a potential total value of...
- The Defense Logistics Agency (DLA) awarded a $9,482.29 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENBREL 50 MG/ML SURECLICK medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The contract has a ceiling value of $18,182.64 and a period of performance through March 15, 2024. This delivery order contract is associated with a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENBREL 50 mg/ml SureClick for $32,221.07. The contract has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds a single award indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564249616 - ENBREL 50 MG/ML SURECLICK ML. The contract has a ceiling value of $14,614.06 and a period of performance through April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDSHADelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENBREL 50 MG/ML SURECLICK medication. The contract has a ceiling value of $27,042.43 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA to the company, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.0k | 4/8/24 |